Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19627139 | 0.89 | KDM4E (0.31) | — | |
| SCHEMBL26323051 | 0.81 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2C19PIK3CAPIK3CG | |
| SCHEMBL19627141 | 0.80 | SLC6A4 (0.37) | CYP1A2CYP3A4CYP2C19SLC6A4OPRM1 | |
| SCHEMBL19627118 | 0.73 | SLC6A4 (0.40) | CYP1A2CYP3A4CYP2C19SLC6A4OPRM1 | |
| SCHEMBL26323050 | 0.72 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2C19PIK3CAPIK3CG | |
| SCHEMBL19627106 | 0.70 | SLC6A4 (0.39) | CYP1A2CYP3A4CYP2C19SLC6A4OPRM1 | |
| SCHEMBL19627136 | 0.69 | KDM4E (0.31) | — | |
| SCHEMBL17793538 | 0.67 | SLC6A4 (0.63) | CYP1A2CYP3A4CYP2C19SLC6A4OPRM1 | |
| SCHEMBL29875858 | 0.67 | SLC6A4 (0.63) | CYP1A2CYP3A4CYP2C19SLC6A4OPRM1 | |
| SCHEMBL29875855 | 0.67 | SLC6A4 (0.63) | CYP1A2CYP3A4CYP2C19SLC6A4OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840541-B2 | Opioid receptor modulators | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2023-12-12 | — | — | US | disclosed |
| US-20230271976-A1 | OPIOID RECEPTOR MODULATORS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2023-08-31 | — | — | US | disclosed |
| US-20170334923-A1 | OPIOID RECEPTOR MODULATORS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334923-A1 | OPIOID RECEPTOR MODULATORS | OPRM1, OPRL1, OPRD1 | CYP1A2 376/4885CYP3A4 390/4885CYP2C19 818/4885 |
| US-20230271976-A1 | OPIOID RECEPTOR MODULATORS | OPRM1, OPRL1, OPRD1 | CYP1A2 489/4885CYP3A4 511/4885CYP2C19 1074/4885 |
| US-11840541-B2 | Opioid receptor modulators | OPRM1, OPRL1, OPRD1 | CYP1A2 376/4885CYP3A4 390/4885CYP2C19 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.